Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Luspatercept Versus Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies

NCT07636486 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT07636486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07636486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Luspatercept Versus Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
June 15, 2026
Completion date
December 31, 2030
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epoetin, hematological malignancies, luspatercept, poor erythroid engraftment